NFE2L2 and bone inflammation disease: Dimethyl fumarate (Tecfidera) activates Nrf2-dependent antioxidant programs, promoting mitochondrial biogenesis and inhibiting pro‐inflammatory cytokine release, and is under investigation for inflammatory bone diseases (Gao et al., 2022; Hayashi et al., 2017).